pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia
BEONE MEDICINES AUS
BEONE MEDICINES AUS PTY LTD
BEONE MEDICINES AUS is a pharma organization headquartered in Cambridge, USA. Primary therapeutic focus areas include Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Solid Tumor, Adult, Mantle Cell Lymphoma, Previous
Cambridge, USA HQ
2010 Founded
3,177 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 3,177
- Programs
- 122
- Drugs
- 63
- Patents
- 0
BGB-11417-302
Phase 3 · small molecule · relapsed or refractory mantle cell lymphoma (R/R MCL)
BGB-11417-302 for relapsed or refractory mantle cell lymphoma (R/R MCL) is a Phase 3 program (small_molecule) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).
Internal code BGB-11417-302
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- BEONE MEDICINES AUS PTY LTD
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- relapsed or refractory mantle cell lymphoma (R/R MCL)
- Status
- active
- Trials
- 1